Ion channel inhibition with amiodarone or verapamil in symptomatic hospitalized nonintensive-care COVID-19 patients: The ReCOVery-SIRIO randomized trial.
Cardiol J
; 29(5): 739-750, 2022.
Article
in En
| MEDLINE
| ID: mdl-35912711
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
/
Amiodarone
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
Cardiol J
Year:
2022
Type:
Article
Affiliation country:
Canada